Clinical Trial Update: Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on palbociclib combined with cetuximab and IMRT for locally advanced head and neck squamous cell carcinoma (phases 1 and 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• IMRT
• Palbociclib (palbociclib)

Snippet

Sponsor: Mahidol University | Conditions: Head and Neck Cancer, Locally Advanced | Phase 1, Phase 2 | Status: UNKNOWN